Baoyao Geometry completes over $100 million A+ funding round
The story so far
BioGeometry has announced the completion of its Series A+ funding, with the total Series A funding exceeding $100 million. This round was led by China Life Capital, with participation from institutions such as Shanghai Biopharma Fund. The funds will be used for the iteration of GeoFlow and GeoCell models, expansion of high-throughput laboratories, and commercialization of self-developed pipelines. The continuous iteration of the GeoFlow (molecular level) and GeoCell (cellular level) models, expansion of high-throughput automated laboratories, and commercialization of self-developed drug pipelines are the key uses of this round of funding.
AI-written from the reports · Updated 22 days ago
Coverage timeline
Follow the coverage to see every side of the story.
- 36Kr · AIBaioc Geometry completes $100 million Series A+ financing
Baiyang Geometry announced the completion of Series A+ financing, with the total amount of Series A financing exceeding 100 million US dollars. This round of financing was led by China Life Capital, with investment from institutions such as Shanghai Biomedical Fund. The funds will be used for the iteration of GeoFlow and GeoCell models, the expansion of high-throughput laboratories, and the commercialization of self-developed pipelines.